Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000431530 | SCV000535471 | likely benign | not specified | 2018-01-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV002063628 | SCV002420845 | likely benign | Adams-Oliver syndrome 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002063628 | SCV002554960 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270482 | SCV002554961 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004017622 | SCV004849166 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2015-09-06 | criteria provided, single submitter | clinical testing | The c.2353+14G>A intronic alteration consists of a G to A substitution 4 nucleotides after coding exon 14 in the NOTCH1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome Diagnostics Laboratory, |
RCV001579562 | SCV001807697 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579562 | SCV001928226 | likely benign | not provided | no assertion criteria provided | clinical testing |